Epidemiology of Huntington’s Disease in the United States Medicare and Medicaid Populations

Abstract

This study suggests that prevalence and incidence of HD in the US may be higher than previously estimated. This has important implications in raising awareness of HD among providers and payers and ensuring availability of and access to services for HD patients and care partners in the Medicare and Medicaid populations.